Tech Company Financing Transactions
Hydra Biosciences Funding Round
On 4/1/2015, Hydra Biosciences raised $10.5 million in investment from private investors.
Transaction Overview
Company Name
Announced On
4/1/2015
Transaction Type
Venture Equity
Amount
$10,507,500
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
45 Moulton St.
Cambridge, MA 02138
USA
Cambridge, MA 02138
USA
Phone
Website
Email Address
Overview
Hydra Biosciences is committed to developing novel drugs to treat important human diseases in major therapeutic areas using its expertise in ion channels and regeneration
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Russell Herndon
Vice President
Bert Chenard
Vice President
Magdalene Moran
VP - Finance
Tom Burke
Browse more venture capital transactions:
Prev: 4/1/2015: Scutify venture capital transaction
Next: 4/1/2015: GoFormz venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs